Genetics of Cannabis Use Disorder and Cannabinoid Response in Humans — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Genetics of Cannabis Use Disorder and Cannabinoid Response in Humans — Stella

Recruiting

Back to Schizophrenia trials

Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.

Trial locations(1 site)

United States

West Haven Veterans Affairs Medical Center, West Haven, Connecticut

Key details

Phase

Early testing

Sponsor

Yale University

Collaborators

National Institute on Drug Abuse (NIDA)

Enrollment target

~215 participants

Started

September 2024

Primary completion

December 2028

Age range

21 Years – 60 Years

Last updated July 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov